Development of bioresorbable polycaprolactone composite mesh for antimicrobial control release and haemostatic properties

DEVELOPMENT OF BIORESORBABLE POLYCAPROLACTONE COMPOSITE MESH FOR ANTIMICROBIAL CONTROL RELEASE AND HAEMOSTATIC PROPERTIES TEO YILING, ERIN (B. Eng, (Hons), NUS) A THESIS SUBMITTED FOR THE DEGREE OF DOCTOR OF PHILOSOPHY DEPARTMENT OF MECHANICAL ENGINEERING NATIONAL UNIVERSITY OF SINGAPORE 2010 Preface Preface This thesis is submitted for the degree of Doctor of Philosophy in the Department of Mechanical Engineering at the National University of Singapore under the supervision of Professor Teoh Swee Hin, Associate Professor Shabbir Moochhala and Associate Professor Lu Jia. No part of this thesis has been submitted for other degree at other university or institution. To the author’s best knowledge, all the work presented in this thesis is original unless reference is made to other works. Parts of this thesis have been published or presented in the List of Publications shown in page ii. Page | i Acknowledgements List of Publications International Journals: 1. Erin Y. Teo, S.Y. Ong, Mark S.K. Chong, Z. Zhang, J. Lu, S. Moochhala, B. Ho, S.H Teoh. Polycaprolactone-based fused deposition modeled mesh for delivery of antibacterial agents to infected wounds. Biomaterials (2011), v32, I1, Pg 279-287. . 2. M.S.K Chong, S.H Teoh, Erin Y. Teo, Z. Zhang, C.N. Lee, S. Koh, M. Choolani, J. Chan. Beyond Cell Capture: Antibody-conjugation Improves Haemocompatibitliy for Vascular Tissue Engineering Applications. Tissue Engineering Part A (2010), v16, I8, pg 2485-2495 3. Z. Zhang, S.H Teoh, Erin Y. Teo, M.S.K. Chong, W.S. Chong, T.T. Foo,M. Choolani, J. Chan. A comparison of bioreactors for culture of fetal mesenchymal stem cells for bone tissue engineering. Biomaterials (2010), v31, I33, pg 86848695. 4. JCM Teo, Erin Y. Teo, VPW Shim and SH Teoh. Determination of bone trabeculae modulus-an ultrasonic scanning and microCT imaging combination approach, Experimental Mechanics, 46 (2006):453-461 Book Chapter: 5. S.H Teoh, B Rai, K S Tiaw, S K M Chong, Z Zhang and Erin Y. Teo. Nano-tomacro Architectures Polycaprolactone-based biomaterials in Tissue Engineering”. In Biomaterials in Asia. World Scientific Publishing Co. Ltd, 2008. Page | ii Acknowledgements International Conferences: 6. Erin Y. Teo, C.K. Chui, V.P.W Shim, S.H. Teoh. Methods and Experiments of Ultrasonic Monitoring of Bone Remodeling. 2nd Materials Research Society (MRS-S) Conference on Advanced Materials. 2006. Singapore. Poster Presentation 7. Erin Y. Teo, Shin-Yeu Ong, Jia Lu, Shabbir Moochhala, S.H. Teoh. Development of Antimicrobial Scaffold for Tissue Engineering Applications. International Conference on Materials for Advanced Technologies (ICMAT) 2007. Singapore. Oral Presentation 8. Erin Y. Teo, Shin-Yeu Ong, Jia Lu, Shabbir Moochhala, S.H. Teoh. Development of 3D Bioactive Scaffolds for Hemostatic Applications. World Congress on Bioengineering (WACBE). Thailand, Bangkok. July 2007. Poster Presentation. 9. Erin Y. Teo, I.S.K Tan, Shin-Yeu Ong, Jia Lu, Shabbir Moochhala, S.H. Teoh. Fabrications of Electrospun Chitosan and its blend. International Conference on Advances in Bioresorbable Biomaterials for Tissue Engineering. ( - Jan 2008, Marina Mandarin Hotel, Singapore) Poster Presentation. 10. Erin Y. Teo, L.H. Yong, Shin-Yeu Ong, Jia Lu, Shabbir Moochhala, S.H. Teoh. Evaluation of the Effects of Tricalcium Phosphate on Platelet Adhesion onto Polycaprolactone sheets. International Conference on Advances in Bioresorbable Page | iii Acknowledgements Biomaterials for Tissue Engineering. ( - Jan 2008, Marina Mandarin Hotel, Singapore). Poster Presentation. 11. Erin. Y. Teo, Shin-Yeu Ong, Jia Lu, Shabbir Moochhala, S.H. Teoh. Evaluation of In Vitro Antimicrobial Efficacy, Elution Profile and Cytotoxicity of Bioactive Polycaprolactone FDM-formed Scaffold. International Conference on Advances in Bioresorbable Biomaterials for Tissue Engineering. (5 - Jan 2008, Marina Mandarin Hotel, Singapore). Oral Presentation 12. Erin. Y. Teo, Shin-Yeu Ong, Jia Lu, Shabbir Moochhala, S.H. Teoh. Evaluation of In Vitro Elution Profile, Antimicrobial Efficacy and Cytotoxicity of 3D Bioactive Polycaprolactone honeycomb scaffold. 2008 Annual Tissue Engineering and Regenerative Medicine International Society- TERMIS-EU. Tissue Engineering Part A. 2008, 14(5): 691-943. Portugal. June 2008. Poster Presentation. 13. Erin Y. Teo, S.H. Teoh, Shin-Yeu Ong, Jia Lu, Shabbir Moochhala. Evaluation of In vivo Antimicrobial Properties of 3D Bioactive Polycaprolactone Honeycomb Scaffold. 2008 Annual Tissue Engineering and Regenerative Medicine International Society-Asia Pacific Region (TERMIS-AP). Taipei, Taiwan. 6-8 November 2008. Oral Presentation. Awarded Best Oral Presentation Award. 14. Mark Chong, Erin Y. Teo, Jerry Chan, Mahesh Choolani, Chuen Neng Lee, Swee Hin Teoh. Generation of Biphasic Constructs from Microthin Biaxially Stretched Polycaprolactone Films. 2008 Annual Tissue Engineering and Regenerative Page | iv Acknowledgements Medicine International Society-Asia Pacific Region (TERMIS-AP). Taipei, Taiwan. 6-8 November 2008. Poster Presentation. Awarded Best Travel Award. 15. S.H. Teoh, Erin Y. Teo, Jia Lu, Shabbir Moochhala. Development of Antimicrobial 3D Polycaprolactone Honeycomb Scaffold. International BoneTissue-Engineering Congress (Bone-tec 2008). Hannover, Germany. 7-9 Novermber 2008. Oral Presentation. 16. Erin Y. Teo, G.Y Tay, S.H Teoh. Drug Elution Characteristics Study of Gentamicin Sulphate Incorporated Polycaprolactone-Tricalcium Phosphate Scaffold. 2nd Asian Biomaterials Congress. Singapore. 26 June-27 June 2009. Oral Presentation. 17. Erin Y. Teo, C.Q Lai, Mark Chong, Jerry Chan, S.H. Teoh. Evaluation of Platelet Adhesion Properties on Polycaprolactone-tricalcium Phosphate film. International Conference on Materials for Advanced Technologies 2009. Singapore. 28 June-3 July 2009. Poster Presentation. 18. Erin Y. Teo, S.H. Teoh, Shin-Yeu Ong, Jia Lu, Shabbir Moochhala. Evaluation of In vivo Antimicrobial Properties of 3D Bioactive Polycaprolactone Honeycomb Scaffold. International Conference on Materials for Advanced Technologies 2009. Singapore. 28 June-3 July 2009. Oral Presentation. Page | v Acknowledgements Acknowledgements I would like to thank my supervisors Professor Teoh Swee Hin, A/Prof Shabbir Moochhala and A/Prof Lu Jia for their teaching, guidance, support and trust after these years of study. This work would not have been possible without them. I would also like to thank my family, my parents, and my beloved brother. Thanks for believing in me, supporting me in whatever I decide to do, caring and worrying for me when I had my accident in the last year of my PhD study. My greatest appreciations would also go to the staff and students of BIOMAT Lab, specifically Dr Mark Chong, Dr Zhang Zhiyong, Dr Tiaw Kay Siang, Asst Prof Chui Chee Kong, Dr Bina Rai, Dr Jeremy Teo, Dr Wen Feng, Puay Siang, all my FYP students and many, many others who have made my life as a PhD student colourful and enjoyable. Thanks for all the help which you have given to me throughout these years. Special thanks also goes to the lab officers of materials lab (Mechanical Engineering), Thomas Tan, Khalim, Aye Thien, Hong Wei, Mdm Zhong; staff of Coagulation lab (Obstetrics and gynaecology), A/Prof Stephen Koh, Bee Lian, Raymond and A/Prof Jerry Chan and Lay Geok from the Experimental Fetal Medicine group (obstetrics and gynaecology). Really appreciate all the help be it in terms of procurement, machine handling, drawing blood etc. Page | vi Acknowledgements I would also like to especially thank the staff of DSO-DMERI Combat Care lab, specifically Shin Yeu, Li Li, Mui Hong, Dr Wu Jian, Cecilia and all others who have helped with my experiments in DSO. My gratitude also goes to A/Prof Ho Bow and Mr Ng Han Chong from microbiology for teaching me so patiently and guiding me through the totally unfamiliar grounds of microbiology. I would also like to thank all staff from Osteopore International Pte Ltd and especially Mr Yew Soi Khoon for helping me with troubleshooting the mesh fabrication. And to all that were not mentioned due to space constraints, thanks for helping me in one way or another. I am deeply grateful. Last but not least, I would like to extend my heartfelt thanks to my husband, Thomas, for standing by me always, tolerating my nonsense when I am stressed out and for simply loving me. Page | vii Summary Summary Tissue traumas are often prone to complications such as haemorrhages and inflammation, which can hinder healing. The challenge is to develop a system that curbs these problems by providing haemostatic and localized controlled antimicrobial effects. The strategy developed in this study involves using a haemostatic fused deposition modeled (FDM)-formed mesh composed of Polycaprolactone (PCL) and 20wt% tricalcium phosphate (TCP), loaded with a model antimicrobial drug, gentamicin sulfate (GS; 15wt%), that will be released within a short duration to inhibit bacterial activity without affecting subsequent tissue regeneration. This platform technology can be applied to a variety of applications requiring interventions of haemostasis and drug elution. A series of in vitro and in vivo experiments were conducted to optimize and characterize this drug eluting haemostatic mesh’s drug eluting and haemostatic aspect. Haemostatic effect was preliminarily evaluated through optimizing the FDM-formed PCL-TCP mesh (85% porosity, 1mm thickness) for blood absorption. PCL was observed to promote platelet adhesion and activation, more prominently than glass positive control. Although in terms of contact activation, PCL performed poorer than glass, it was still regarded as a relevant haemostat as it showed significant haemostatic properties comparing to negative control. Upon adding TCP, both surface chemistry and topography were altered. To isolate surface topography effect, experimentations on gold sputtered specimens showed a decrease in platelet adhesion with increased surface roughness due to increasing TCP Page | viii Summary incorporation (0-25wt%). When evaluated with surface chemistry effect, it yielded a general increase in platelet coverage with increasing TCP content. In the balance of the two aspects, PCL with 20wt% TCP was selected for its optimal platelet adhesion. Architectural influence to haemostasis was also studied by comparing micro-scaled (FDM), sub-micron (nanofibers) and macro-scaled (film) architectures. It was shown that FDM-formed PCL structures had comparable blood contact activation and platelet adhesion to glass, justifying its use for this system. For the antimicrobial aspect, the incorporation of GS was optimised. 15wt% GS incorporation rendered most efficient even with bacterial reinoculations. 93% of total GS was released within 168 hours and was found to be non-cytotoxic to human dermal fibroblast. The burst release can be attributed to the hydrophilic surfaces caused by high TCP content in the FDM-formed mesh, with direct relation found between GS release rate and TCP content. Therefore, TCP content of 20wt% was once again chosen for optimum GS release during the critical infectious period while allowing subsequent tissue regeneration. When tested against gauze using an infected full-thickness wound mice model, the mesh eliminated the bacteria in wound effectively with no observable signs of overall infection after days, led to excellent wound healing with 94.2% reduction in wound area by day 14 and stimulated faster wound healing as indicated from the improved neo-collagen deposition and re-epithelisation. Page | ix Bibliography 60. Huang X, Brazel CS. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release 2001 Jun 15;73(2-3):121136. 61. Huang ZM, Zhang YZ, Kotaki M, Ramakrishna S. A review on polymer nanofibers by electrospinning and their applications in nanocomposites. Composties Sci & Tech 2003(63):2223-2253. 62. Hutmacher DW, Schantz T, Zein I, Ng KW, Teoh SH, Tan KC. Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. J Biomed Mater Res 2001 May;55(2):203216. 63. Ip M, Lui SL, Poon VK, Lung I, Burd A. Antimicrobial activities of silver dressings: an in vitro comparison. J Med Microbiol 2006 Jan;55(Pt 1):59-63. 64. ISO IS. Biological evaluation of medical devices. . Part 4: Selection of tests for interactions with blood. Brussels, 2002. 65. Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000 Dec;21(23):2475-2490. 66. Jin HJ, Fridrikh SV, Rutledge GC, Kaplan DL. Electrospinning Bombyx mori silk with poly(ethylene oxide). Biomacromolecules 2002 Nov-Dec;3(6):1233-1239. Page | 123 Bibliography 67. Johnson P, Fromm D. Effects of bone wax on bacterial clearance. Surgery 1981 Feb;89(2):206-209. 68. Katz SE, Rootman J. Adverse effects of bone wax in surgery of the orbit. Ophthal Plast Reconstr Surg 1996 Jun;12(2):121-126. 69. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma 2006 Jun;60(6 Suppl):S3-11. 70. Khang G, Choi H-s, Rhee JM, Yoon SC, Cho JC, Lee HB. Controlled release of gentamicin sulfate from poly(3-hydroxybutyrate-co-3-hydroxyvalerate) wafers for the treatment of osteomyelitis. Korea Polymer Journal 2000;8(6):253-260. 71. Kilpadi KL, Chang PL, Bellis SL. Hydroxylapatite binds more serum proteins, purified integrins, and osteoblast precursor cells than titanium or steel. J Biomed Mater Res 2001 Nov;57(2):258-267. 72. Kim TG, Lee DS, Park TG. Controlled protein release from electrospun biodegradable fiber mesh composed of poly(epsilon-caprolactone) and poly(ethylene oxide). Int J Pharm 2007 Jun 29;338(1-2):276-283. 73. Kimura Y, editor. Biodegradable polymers: CRC press, 1993. Page | 124 Bibliography 74. Kingsley A. The wound infection continuum and its application to clinical practice. Ostomy Wound Manage 2003 Jul;49(7A Suppl):1-7. 75. Kirker KR, Luo Y, Nielson JH, Shelby J, Prestwich GD. Glycosaminoglycan hydrogel films as bio-interactive dressings for wound healing. Biomaterials 2002 Sep;23(17):3661-3671. 76. Ko T-M, Cooper S. Surface properties and platelet adhesion characteristics of acrylic acid and allylamine plasma-treated polyethylene Journal Applied Polymer Science 1993;47:1601-1619. 77. Koc Y, de Mello AJ, McHale G, Newton MI, Roach P, Shirtcliffe NJ. Nano- scale superhydrophobicity: suppression of protein adsorption and promotion of flowinduced detachment. Lab Chip 2008 Apr;8(4):582-586. 78. Koh LB, Rodriguez I, Venkatraman SS. The effect of topography of polymer surfaces on platelet adhesion. Biomaterials 2010 Mar;31(7):1533-1545. 79. Kumar CG, Himabindu M, Jetty A. Microbial biosynthesis and applications of gentamicin: a critical appraisal. Crit Rev Biotechnol 2008;28(3):173-212. 80. Laffargue P, Hildebrand HF, Rtaimate M, Frayssinet P, Amoureux JP, Marchandise X. Evaluation of human recombinant bone morphogenetic protein-2loaded tricalcium phosphate implants in rabbits' bone defects. Bone 1999 Aug;25(2 Suppl):55S-58S. Page | 125 Bibliography 81. Lawson JH, Lynn KA, Vanmatre RM, Domzalski T, Klemp KF, Ortel TL, et al. Antihuman factor V antibodies after use of relatively pure bovine thrombin. Ann Thorac Surg 2005 Mar;79(3):1037-1038. 82. Lazzarini L, Mader JT, Calhoun JH. Osteomyelitis in long bones. J Bone Joint Surg Am 2004 Oct;86-A(10):2305-2318. 83. Lemm W, Unger V, Bucherl ES. Blood compatibility of polymers: in vitro and in vivo tests. Med Biol Eng Comput 1980 Jul;18(4):521-526. 84. Leong KF, Wiria FE, Chua CK, Li SH. Characterization of a poly-epsilon- caprolactone polymeric drug delivery device built by selective laser sintering. Biomed Mater Eng 2007;17(3):147-157. 85. Li S HSG, Vert M. Hydrolytic degradation of poly(D, L-lactoc acid) in the presence of caffeine base. J Cont Rel 1996(40):41-53. 86. Luo Q, Andrade JD. Cooperative Adsorption of Proteins onto Hydroxyapatite. Journal of Colloid and interface science 1998;200:104-113. 87. Maquet V, Boccaccini AR, Pravata L, Notingher I, Jerome R. Porous poly(alpha-hydroxyacid)/Bioglass composite scaffolds for bone tissue engineering. I: Preparation and in vitro characterisation. Biomaterials 2004 Aug;25(18):4185-4194. Page | 126 Bibliography 88. Marques AP, Reis RL, Hunt JA. The biocompatibility of novel starch-based polymers and composites: in vitro studies. Biomaterials 2002 Mar;23(6):1471-1478. 89. Martineau L, Shek PN. Evaluation of a bi-layer wound dressing for burn care. II. In vitro and in vivo bactericidal properties. Burns 2006 Mar;32(2):172-179. 90. Martinez-Salgado C, Lopez-Hernandez FJ, Lopez-Novoa JM. Glomerular nephrotoxicity of aminoglycosides. Toxicol Appl Pharmacol 2007 Aug 15;223(1):8698. 91. Mast BA, editor. The Skin. Philadelphia, Pa, USA: WB Saunders, 1999. 92. McManus JG, Eastridge BJ, Wade CE, Holcomb JB. Hemorrhage control research on today's battlefield: lessons applied. J Trauma 2007 Jun;62(6 Suppl):S14. 93. Mi FL, Wu YB, Shyu SS, Schoung JY, Huang YB, Tsai YH, et al. Control of wound infections using a bilayer chitosan wound dressing with sustainable antibiotic delivery. J Biomed Mater Res 2002 Mar 5;59(3):438-449. 94. Miyai T, Ito A, Tamazawa G, Matsuno T, Sogo Y, Nakamura C, et al. Antibiotic-loaded poly-epsilon-caprolactone and porous beta-tricalcium phosphate composite for treating osteomyelitis. Biomaterials 2008 Jan;29(3):350-358. 95. Moulin V, Auger FA, Garrel D, Germain L. Role of wound healing myofibroblasts on re-epithelialization of human skin. Burns 2000 Feb;26(1):3-12. Page | 127 Bibliography 96. Murray CK, Roop SA, Hospenthal DR, Dooley DP, Wenner K, Hammock J, et al. Bacteriology of war wounds at the time of injury. Mil Med 2006 Sep;171(9):826829. 97. Ng C.S. TSH, Chung T.S, D.W Hutmacher. Simultaneous biaxial drawing of poly(E-caprolactone) films. Polymer 2000(41):5855-5864. 98. Noorjahan SE, Sastry TP. An in vivo study of hydrogels based on physiologically clotted fibrin-gelatin composites as wound-dressing materials. J Biomed Mater Res B Appl Biomater 2004 Nov 15;71(2):305-312. 99. Nygren H, Tengvall P, Lundstrom I. The initial reactions of TiO2 with blood. Journal of Biomedical Materials Research 1996;34(4):487-492. 100. Ong SY, Wu J, Moochhala SM, Tan MH, Lu J. Development of a chitosan- based wound dressing with improved hemostatic and antimicrobial properties. Biomaterials 2008 Nov;29(32):4323-4332. 101. Orii H, Sotome S, Chen J, Wang J, Shinomiya K. Beta-tricalcium phosphate (beta-TCP) graft combined with bone marrow stromal cells (MSCs) for posterolateral spine fusion. J Med Dent Sci 2005 Mar;52(1):51-57. 102. Park J.B RSL. Biomaterials- an introduction. 2nd ed. New York: Plenum Press, 1992. Page | 128 Bibliography 103. Park JB, Lake RS. Biomaterials- an introduction. 2nd ed. New York: Plenum Press, 1992. 104. Park JY, Gemmell CH, Davies JE. Platelet interactions with titanium: modulation of platelet activity by surface topography. Biomaterials 2001 Oct;22(19):2671-2682. 105. Park K. Controlled drug delivery: challenges and strategies. Washington, D.C., 629: Americal Chemical Society, 1997. 106. Perez MH, Zinutti, C., Lamprecht, A., Maincent, P. The preparation and evaluation of poly-caprolactone microparticles containing both lipophilic and hydrophilic drug. J Cont Rel 2001(65):429-438. 107. Petropoulos J.H PKG, Amarantos S.G. A general model for the release of active agents incorporated in swellable polymeric matrices. J Pol Sci B: Pol Phys 1992(30):717-725. 108. Pitt CG, editor. Non-microbial degradation of polyesters: Mechanisms and Modifications. Cambridge: The Royal Society of Chemistry, 1992. Page | 129 Bibliography 109. Pitt CG, Gratzl MM, Jeffcoat AR, Zweidinger R, Schindler A. Sustained drug delivery systems II: Factors affecting release rates from poly(epsilon-caprolactone) and related biodegradable polyesters. J Pharm Sci 1979 Dec;68(12):1534-1538. 110. Pitt CG, Gratzl MM, Kimmel GL, Surles J, Schindler A. Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (epsilon-caprolactone), and their copolymers in vivo. Biomaterials 1981 Oct;2(4):215-220. 111. Pitt CG, Jeffcoat AR, Zweidinger RA, Schindler A. Sustained drug delivery systems. I. The permeability of poly(epsilon-caprolactone), poly(DL-lactic acid), and their copolymers. J Biomed Mater Res 1979 May;13(3):497-507. 112. Pitt WG, Park K, Cooper SL. Sequential Protein adsorption and thrombus deposition on polymeric biomaterials. Journal of Colloid and interface science 1986;111:343-362. 113. Prince MR, Salzman EW, Schoen FJ, Palestrant AM, Simon M. Local intravascular effects of the nitinol wire blood clot filter. Invest Radiol 1988 Apr;23(4):294-300. 114. Quick AJ, Stefanini M. The chemical state of the calcium reacting in the coagulation of blood. J Gen Physiol 1948 Nov;32(2):191-202. 115. Ragel CV, Vallet-Regi M. In vitro bioactivity and gentamicin release from glass-polymer-antibiotic composites. J Biomed Mater Res 2000 Sep 5;51(3):424-429. Page | 130 Bibliography 116. Rai B, Teoh SH, Ho KH. An in vitro evaluation of PCL-TCP composites as delivery systems for platelet-rich plasma. J Control Release 2005 Oct 3;107(2):330342. 117. Rai B, Teoh SH, Hutmacher DW, Cao T, Ho KH. Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2. Biomaterials 2005 Jun;26(17):3739-3748. 118. Rathbone MJ, Hadgraft J, Michael SR. Modified-release drug delivery technology. New York: Marcel Dekker, 2003. 119. Ratner BD. Blood compatibility--a perspective. J Biomater Sci Polym Ed 2000;11(11):1107-1119. 120. Ratner BD, Hoffman AS, Schoen FJ, Lemons JE. Biomaterials science: an introduction to materials in medicine. New York: Elsevier Sci, 1996. 121. Robicsek F, Masters TN, Littman L, Born GV. The embolization of bone wax from sternotomy incisions. Ann Thorac Surg 1981 Apr;31(4):357-359. 122. Robinson JR. Sustained and controlled release drug delivery systems. New York: Marcel Dekker, 1978. Page | 131 Bibliography 123. Robson M, Kucukcelebi A, Carp SS, Hayward PG, Hui PS, Cowan WT, et al. Effects of granulocyte-macrophage colony-stimulating factor on wound contraction. Eur J Clin Microbiol Infect Dis 1994;13 Suppl 2:S41-46. 124. Rougier F, Claude D, Maurin M, Maire P. Aminoglycoside nephrotoxicity. Curr Drug Targets Infect Disord 2004 Jun;4(2):153-162. 125. Rousou J, Levitsky S, Gonzalez-Lavin L, Cosgrove D, Magilligan D, Weldon C, et al. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. J Thorac Cardiovasc Surg 1989 Feb;97(2):194-203. 126. Rutledge B, Huyette D, Day D, Anglen J. Treatment of osteomyelitis with local antibiotics delivered via bioabsorbable polymer. Clin Orthop Relat Res 2003 Jun(411):280-287. 127. Saltzman WM. Drug delivery. New York: Oxford Univeristy Press, 2001. 128. Sarasam A, Madihally SV. Characterization of chitosan-polycaprolactone blends for tissue engineering applications. Biomaterials 2005 Sep;26(27):5500-5508. 129. Schantz JT, Hutmacher DW, Chim H, Ng KW, Lim TC, Teoh SH. Induction of ectopic bone formation by using human periosteal cells in combination with a novel scaffold technology. Cell Transplant 2002;11(2):125-138. Page | 132 Bibliography 130. Schmaier AH. Contact activation: a revision. Thromb Haemost 1997 Jul;78(1):101-107. 131. Schoenecker JG, Johnson RK, Lesher AP, Day JD, Love SD, Hoffman MR, et al. Exposure of mice to topical bovine thrombin induces systemic autoimmunity. Am J Pathol 2001 Nov;159(5):1957-1969. 132. Schwope AD, Wise DL, Sell KW, Dressler DP, Skornick WA. Evaluation of wound-covering materials. J Biomed Mater Res 1977 Jul;11(4):489-502. 133. Schwope AD, Wise DL, Sell KW, Skornik WA, Dressler DP. Development of a synthetic burn covering. Trans Am Soc Artif Intern Organs 1974;20A:103-107. 134. Selkon JB. The bacteriology of war wounds. J R Nav Med Serv 1981;67(3):160-164. 135. Setterstrom JA, Tice TR, Meyers WE, Vincent JW. Development of encapsulated antibiotics for topical administration to wounds. Second World Congress on Biomaterials 10th Annual Meeting of the Society for Biomaterials. Washington, DC, 1984. p. 4. 136. Shapiro NI, Wolfe RE, Wright SB, Moore R, Bates DW. Who needs a blood culture? A prospectively derived and validated prediction rule. J Emerg Med 2008 Oct;35(3):255-264. Page | 133 Bibliography 137. Shinto Y, Uchida A, Korkusuz F, Araki N, Ono K. Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. J Bone Joint Surg Br 1992 Jul;74(4):600-604. 138. Shiozuka M, Wagatsuma A, Kawamoto T, Sasaki H, Shimada K, Takahashi Y, et al. Transdermal delivery of a readthrough-inducing drug: a new approach of gentamicin administration for the treatment of nonsense mutation-mediated disorders. J Biochem 2009 Nov 11. 139. Siegel SJ, Kahn JB, Metzger K, Winey KI, Werner K, Dan N. Effect of drug type on the degradation rate of PLGA matrices. Eur J Pharm Biopharm 2006 Nov;64(3):287-293. 140. Siepmann J, Gopferich A. Mathematical modeling of bioerodible, polymeric drug delivery systems. Adv Drug Deliv Rev 2001 Jun 11;48(2-3):229-247. 141. Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Poly-epsilon- caprolactone microspheres and nanospheres: an overview. Int J Pharm 2004 Jun 18;278(1):1-23. 142. Somasundaran P, editor. Surface chemical characteristics and adsorption properties of apatite. New York, USA: Plenum Press, 1984. 143. Spahn CM, Prescott CD. Throwing a spanner in the works: antibiotics and the translation apparatus. J Mol Med 1996 Aug;74(8):423-439. Page | 134 Bibliography 144. Spijker HT, Graaff R, Boonstra PW, Busscher HJ, van Oeveren W. On the influence of flow conditions and wettability on blood material interactions. Biomaterials 2003 Nov;24(26):4717-4727. 145. Stallmann H, Faber C, Bronckers A, Nieuw Amerongen A, Wuisman P. In vitro gentamicin release from commercially available calcium-phosphate bone substitutes influence of carrier type on duration of the release profile. BMC Musculoskeletal Disorders 2006;7(1):18. 146. Steiling H, Munz B, Werner S, Brauchle M. Different types of ROS- scavenging enzymes are expressed during cutaneous wound repair. Exp Cell Res 1999 Mar 15;247(2):484-494. 147. Strodtbeck F. Physiology of Wound healing. Newborn and Infant Nursing Reviews 2001;1(1):43-52. 148. Sung K.C HRY, Hy O.Y.O, Hsu L.R. Controlled release of nalbuphone prodrugs from biodegradable polymeric matrices: influence of prodrug hydrophilicity and polymer composition. Int J Pharm 1998;172:17-25. 149. Sweileh WM. Gender differences in aminoglycoside induced nephrotoxicity: a prospective, hospital-based study. Curr Clin Pharmacol 2009 Sep;4(3):229-232. Page | 135 Bibliography 150. Tan TC, Black, P.M. Sir Victor Horsley (1857-1916): a pioneer of neurological surgery. Neurosurgery 2002(50):607-612. 151. Teoh SH, editor. Introduction to biomaterials engineering and processing- an overview. 1st ed. Singapore: World Scientific Publishing Co. Pte Ltd, 2004. 152. Teoh SH, Rai B, Tiaw KS, Chong SKM, Zhang Z, Teo YE, editors. Nano-to- macro architectures polycaprolactone-based biomaterials in tissue engineering: World Scientific, 2008. 153. Tomizawa Y. Clinical benefits and risk analysis of topical hemostats: a review. J Artif Organs 2005;8(3):137-142. 154. Tozum TF, Demiralp B. Platelet-rich plasma: a promising innovation in dentistry. J Can Dent Assoc 2003 Nov;69(10):664. 155. Tunney MM, Patrick S, Gorman SP, Nixon JR, Anderson N, Davis RI, et al. Improved detection of infection in hip replacements. A currently underestimated problem. J Bone Joint Surg Br 1998 Jul;80(4):568-572. 156. van de Belt H, Neut D, van Horn JR, van der Mei HC, Schenk W, Busscher HJ. .or not to treat? Nat Med 1999 Apr;5(4):358-359. 157. van Oeveren W, Haan J, Lagerman P, Schoen P. Comparison of coagulation activity tests in vitro for selected biomaterials. Artif Organs 2002 Jun;26(6):506-511. Page | 136 Bibliography 158. Vogler EA, Siedlecki CA. Contact activation of blood-plasma coagulation. Biomaterials 2009 Apr;30(10):1857-1869. 159. Waldrop J, Doughty D, editors. Wound-healing physiology. ed. St Louis, MO, Mosby, 1991. 160. Wang MY, Armstrong JK, Fisher TC, Meiselman HJ, McComb GJ, Levy ML. A new, pluronic-based, bone hemostatic agent that does not impair osteogenesis. Neurosurgery 2001 Oct;49(4):962-967; discussion 968. 161. Wassell DT, Hall RC, Embery G. Adsorption of bovine serum albumin onto hydroxyapatite. Biomaterials 1995 Jun;16(9):697-702. 162. Wellisz T, Armstrong JK, Cambridge J, An YH, Wen X, Kang Q, et al. The effects of a soluble polymer and bone wax on sternal healing in an animal model. Ann Thorac Surg 2008 May;85(5):1776-1780. 163. Wenker OC, Wojciechowski Z, Sheinbaum R, Zisman E. Thromboelastography. The Internet Journal of Anesthesiology 1997;1(3). 164. Whitten CW, Greilich PE. Thromboelastography: past, present, and future. Anesthesiology 2000 May;92(5):1223-1225. Page | 137 Bibliography 165. Wilkinson HA, Baker S, Rosenfeld S. Gelfoam paste in experimental laminectomy and cranial trephination: hemostasis and bone healing. J Neurosurg 1981 May;54(5):664-667. 166. X. Fang DHR. DNA Fibers by electrospinning. J Macro Sci 1997(36):169-173. 167. Y. Lei BR, K.H. Ho, S.H. Teoh. In vitro degradation of novel bioactive polycaprolactone-20% tricalcium phosphate composite scaffolds for bone engineering. Materials Science and Engineering C 2007(27):293-298. 168. Yang YY, Chung TS, Ng NP. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 2001 Feb;22(3):231-241. 169. Zein I, Hutmacher DW, Tan KC, Teoh SH. Fused deposition modeling of novel scaffold architectures for tissue engineering applications. Biomaterials 2002 Feb;23(4):1169-1185. 170. Zhang H, Zhao CG, Zhao YH, Tang GW, Yuan XY. Electrospinning of ultrafine core/shell fibers for biomedical applications. Sci China-Chem 2010 Jun;53(6):1246-1254. 171. Zhou C, Yi Z. Blood-compatibility of polyurethane/liquid crystal composite membranes. Biomaterials 1999 Nov;20(22):2093-2099. Page | 138 [...]... inoculations of bacteria The eluted amounts of gentamicin sulfate are also hypothesized to be non-cytotoxic b To evaluate the effect of TCP incorporation in platform mesh on drug elution Hypothesis: With the addition of TCP, the rate of release of drug will be increased over a period of time due to the lowering of hydrophobicity of the platform mesh c To demonstrate that the antimicrobial incorporated mesh. .. the haemostatic properties of the mesh, individual component material and the influence of mesh architecture on the blood clotting using various assays Chapter 5 is on various antibacterial analyses done to evaluate the elution profile, antimicrobial efficacy and cytotoxicity of the various concentrations of GS incorporated The influence of TCP incorporation and surface area to volume ratio of platform... with the best blood absorption capacity for use throughout this work b To study the haemostatic effect of PCL before and after the incorporation of TCP Hypothesis: With the incorporation of TCP into the PCL mesh, haemostatic properties will be improved c To study the effect of different scale of mesh architecture (nano, micro and macro) on blood clotting Hypothesis: Meshes with micro-scaled topographies,... stages and morphology description of platelet activation for the detection of extent in activation of adhered platelets [Ko and Cooper 1993] 48 Figure 4-2 Schematic representation of TEG plot and derivation of the parameters 49 Figure 4-3 SEM micrographs of A) Glass slide after 60 min of immersion in PRP at magnification of 500x, B) PCL after 60 min of immersion in PRP at magnification of 500x... appropriate ones for our application Finally, the principles of biomaterials engineering and the status of the current drug eluting and haemostatic meshes and technologies are reviewed in this chapter 2.2 Haemostasis and blood coagulation In common cases, bleeding occur once there is a disruption of blood vessels and without the timely arrest of the bleeding, hemorrhage and large volume of blood loss... architecture The antimicrobial drugs will then be incorporated into the synthetic polymeric mesh for the localized release at wound or implant sites, with the TCP component and the general mesh FDM architecture to serve the haemostatic function Page | 3 Chapter 1: Introduction 1.2 Research aim and proposal outline The primary goal of this study was to develop and evaluate haemostatic PCL-TCP meshes for the... the delivery of antimicrobial drugs to wound or implant sites and sustain the elution concentrations above the minimum inhibitory concentration for a period of time This was tested out in both in vitro and in vivo environments To achieve this, the specific aims for this study were as follows: 1 For the haemostatic aspect of the study: a To ascertain the configuration and architecture of the mesh with... amplitude of TEG plot, that is indicative of the ultimate strength of the fibrin clot as an indication of surface consumption of clotting proteins 73 Figure 4-21 Blood clotting index measurement for comparison of different architectures 74 Page | xxii List of Figures Figure 5-1 Cumulative Elution Profile of 5wt%, 15wt% and 25wt% GS incorporated PCL-TCP mesh (in terms of percentage... List of Figures Figure 4-15 Graph of percentage area covered by platelets onto PCL-TCP specimens with different percentages of TCP 64 Figure 4-16 Representative SEM micrographs of platelets attached on (a) glass (b) nanofibers (c) FDM-formed mesh (d) film at magnification of 2500x 68 Figure 4-17 Reaction time for fibrin formation Comparing PCL with different scales of architecture and. .. improved haemostatic properties Page | 4 Chapter 1: Introduction 2 For the antimicrobial aspect of the study: a To evaluate the antimicrobial elution profile and its efficacy to eliminate bacteria over time and with repeated inoculation of bacteria while monitoring its cytotoxic effect Hypothesis: The incorporated model drug, gentamicin sulfate, will be eluted over the critical infectious period and retain . DEVELOPMENT OF BIORESORBABLE POLYCAPROLACTONE COMPOSITE MESH FOR ANTIMICROBIAL CONTROL RELEASE AND HAEMOSTATIC PROPERTIES TEO YILING, ERIN. interventions of haemostasis and drug elution. A series of in vitro and in vivo experiments were conducted to optimize and characterize this drug eluting haemostatic mesh s drug eluting and haemostatic. In Vitro Antimicrobial Efficacy, Elution Profile and Cytotoxicity of Bioactive Polycaprolactone FDM-formed Scaffold. International Conference on Advances in Bioresorbable Biomaterials for Tissue